Qube Research & Technologies (QRT)’s Meridian Bioscience Inc VIVO Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-402,964	Closed	-$13.4M	–	3184
2022 Q4	$13.4M	Buy	402,964 +151,133	+60%	+$4.87M	0.07%	391
2022 Q3	$7.94M	Buy	251,831 +230,026	+1,055%	+$7.45M	0.05%	479
2022 Q2	$663K	Buy	+21,805	New	+$590K	﹤0.01%	1296
2020 Q1	–	Sell	-39,542	Closed	-$386K	–	1808
2019 Q4	$386K	Buy	+39,542	New	+$371K	0.01%	1087

Other funds holding VIVO

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Qube Research & Technologies (QRT)'s VIVO Position: Q1 2023 in Review

Qube Research & Technologies (QRT) sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 402,964 shares — an estimated $13.4M sold.

Qube Research & Technologies (QRT) first reported a position in VIVO in Q4 2019 and held it in 4 quarters. The position peaked at $13.4M in Q4 2022. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

Qube Research & Technologies (QRT) reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
Qube Research & Technologies (QRT) sold 402,964 Meridian Bioscience Inc shares in Q1 2023, an estimated $13.4M.
Qube Research & Technologies (QRT) first reported a position in Meridian Bioscience Inc in Q4 2019 and held it in 4 quarters.
Qube Research & Technologies (QRT)'s Meridian Bioscience Inc position peaked at $13.4M in Q4 2022.
2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2023, filed 15 May 2023.